[Treatment of bronchial asthma exacerbation].
The purpose of this study was to present the actual possibilities of bronchial asthma exacerbation control. The role of viral infection, especially, human metapneumovirus infection may be a leading cause of disease exacerbation in children population. Prevalence of gastroesophageal reflux had been detected in 24% of asthmatic patients, in some cases as a cause of asthma exacerbation. Glucocorticosteroid therapy is accepted as cardinal in asthma exacerbation, but some adverse effects create a control limit.
Płusa
Tadeusz
T
Wojskowy Instytut Medyczny, Klinika Chorób Wewnetrznych, Pneumonologii i Alergologii CSK MON w Warszawie.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000209:etiology* / Q000821:virology; D001993:Bronchodilator Agents / Q000627:therapeutic use; D004357:Drug Synergism; D005764:Gastroesophageal Reflux / Q000150:complications*; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D029121:Metapneumovirus; D018184:Paramyxoviridae Infections / Q000150:complications*; D013806:Theophylline / Q000627:therapeutic use; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents; D020024:Leukotriene Antagonists; D013806:Theophylline